Oncology PracticeDirect access to unexpected genetic test resultsMarch 11, 2013Preventive CareBreast Cancer
The Journal of Community and Supportive OncologyTrastuzumab emtansine in advanced HER2-positive breast cancerMarch 1, 2013Breast Cancer
The Journal of Community and Supportive OncologyTreatment patterns in HER2-/HR-positive postmenopausal women with metastatic breast cancer initiating first-line treatment in a community oncology setting in the USMarch 1, 2013Breast CancerPatient & Survivor Care
The Journal of Community and Supportive OncologyA randomized, double-blind, placebo-controlled study of oral coenzyme Q 10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancerMarch 1, 2013Breast CancerPatient & Survivor Care
The Journal of Community and Supportive OncologyRelationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32March 1, 2013Breast CancerPatient & Survivor Care
Oncology PracticeMetastatic breast cancer incidence is rising among young womenFebruary 26, 2013Breast Cancer
Oncology PracticeKadcyla wins FDA approval for late-stage breast cancerFebruary 22, 2013Breast Cancer
Oncology PracticeBreast-conserving therapy improved survival over mastectomyFebruary 12, 2013Breast Cancer
Oncology PracticeSome HER2-negative cancers may benefit from anti-HER2 therapyFebruary 4, 2013Breast Cancer
The Journal of Community and Supportive OncologyCost-benefit analysis of decision support methods for patients with breast cancer in a rural communityFebruary 1, 2013Breast Cancer
